The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, NRX Pharmaceuticals Inc’s stock clocked out at $2.69, up 1.89% from its previous closing price of $2.64. In other words, the price has increased by $1.89 from its previous closing price. On the day, 0.54 million shares were traded. NRXP stock price reached its highest trading level at $2.8197 during the session, while it also had its lowest trading level at $2.66.
Ratios:
To gain a deeper understanding of NRXP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.11 and its Current Ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 02, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 17 ’24 when Javitt Jonathan C bought 40,000 shares for $1.17 per share. The transaction valued at 46,800 led to the insider holds 84,634 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRXP now has a Market Capitalization of 53006720 and an Enterprise Value of 58965404.
Stock Price History:
The Beta on a monthly basis for NRXP is 1.64, which has changed by 0.39378238 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, NRXP has reached a high of $6.01, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is -9.41%, while the 200-Day Moving Average is calculated to be 10.13%.
Shares Statistics:
It appears that NRXP traded 274.12K shares on average per day over the past three months and 500060 shares per day over the past ten days. A total of 23.77M shares are outstanding, with a floating share count of 19.71M. Insiders hold about 17.08% of the company’s shares, while institutions hold 25.22% stake in the company. Shares short for NRXP as of 1753920000 were 614859 with a Short Ratio of 2.24, compared to 1751241600 on 901880. Therefore, it implies a Short% of Shares Outstanding of 614859 and a Short% of Float of 3.47.
Earnings Estimates
The stock of NRX Pharmaceuticals Inc (NRXP) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $0.21, with high estimates of $0.21 and low estimates of $0.21.
Analysts are recommending an EPS of between $0.15 and $0.15 for the fiscal current year, implying an average EPS of $0.15. EPS for the following year is $0.5, with 1.0 analysts recommending between $0.5 and $0.5.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $1M. There is a high estimate of $1M for the next quarter, whereas the lowest estimate is $1M. Based on 3 analysts’ estimates, the company’s revenue will be $127.99M in the next fiscal year. The high estimate is $241.4M and the low estimate is $42.57M.
